TapewireFind a company

person · Reporting owner

Khayal Tamer I

Disclosed activity across 1 company

Tapewire entity
82348
SEC CIK
0001430462

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
TransMedics Group, Inc.TMDX · Entity 4261Chief Commercial OfficerMarch 03, 2025March 05, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

TransMedics Group, Inc.

Report date March 03, 2025 · Filed March 05, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect36,042 Reported balance After 2025-03-03 transaction · row 1
1 source row

Row 1 · 2025-03-03 · Sale · Disposed 2,407 · Balance 36,042

F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Filing footnotes · ownership attribution and instrument terms

F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 5, 2024 18:28 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 1,234 $85.18 $105,112.12
Disclosure

SEC source: 0000950170-24-026492 · ownership.xml · nonDerivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,502

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.035 to $85.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 18:28 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 424 $84.26 $35,726.24
Disclosure

SEC source: 0000950170-24-026492 · ownership.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,736

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.07 to $84.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 18:28 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 3,632 $83.64 $303,780.48
Disclosure

SEC source: 0000950170-24-026492 · ownership.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,160

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $83.00 to $83.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 18:28 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 1,842 $82.28 $151,559.76
Disclosure

SEC source: 0000950170-24-026492 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,792

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.01 to $82.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 18:28 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,868 $81.49 $233,713.32
Disclosure

SEC source: 0000950170-24-026492 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,634

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $81.01 to $81.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 18:28 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 10,000 $13.28 $132,800.00
Disclosure

SEC source: 0000950170-24-026492 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 GrantStock Option (Right to Buy) · Derivative 18,690 $0.00 Strike: $83.14 $0.00
Disclosure

SEC source: 0000950170-24-021330 · ownership.xml · derivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,690

Underlying: Common Stock · 18,690 shares

Expires 2034-02-23

F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 23, 2024 until the option is fully vested on February 23, 2028, subject to continued service.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 GrantCommon Stock 12,127 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-021330 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,502

F1 · shares: Consists of 12,127 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 250 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · derivative · entry 10

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,746

Underlying: Common Stock · 250 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 250 $90.00 $22,500.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 20, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 250 $16.14 $4,035.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,714 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · derivative · entry 9

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,996

Underlying: Common Stock · 1,714 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,144 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · derivative · entry 8

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,144 shares

Expires 2029-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,858 $90.00 $257,220.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.035, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,714 $16.14 $27,663.96
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 17:01 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,144 $16.00 $18,304.00
Disclosure

SEC source: 0000950170-24-018047 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,519

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 17:25 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 776 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000950170-24-016560 · ownership.xml · derivative · entry 8

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,144

Underlying: Common Stock · 776 shares

Expires 2029-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 17:25 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 776 $90.00 $69,840.00
Disclosure

SEC source: 0000950170-24-016560 · ownership.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.005, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 17:25 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 776 $16.00 $12,416.00
Disclosure

SEC source: 0000950170-24-016560 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,151

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 17:25 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 3,050 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000950170-24-016560 · ownership.xml · derivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,920

Underlying: Common Stock · 3,050 shares

Expires 2029-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 17:25 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 3,050 $90.03 $274,591.50
Disclosure

SEC source: 0000950170-24-016560 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 17:25 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 3,050 $16.00 $48,800.00
Disclosure

SEC source: 0000950170-24-016560 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 18:35 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 736 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000950170-24-013458 · ownership.xml · derivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,970

Underlying: Common Stock · 736 shares

Expires 2029-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · derivative.exercise_date: The option is fully vested.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 18:35 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 736 $90.09 $66,306.24
Disclosure

SEC source: 0000950170-24-013458 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.01 to $90.185, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 18:35 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 736 $16.00 $11,776.00
Disclosure

SEC source: 0000950170-24-013458 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 2,330 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0000950170-24-007427 · ownership.xml · derivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,706

Underlying: Common Stock · 2,330 shares

Expires 2029-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F4 · derivative.exercise_date: The option is fully vested.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,330 $90.09 $209,909.70
Disclosure

SEC source: 0000950170-24-007427 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 2,330 $16.00 $37,280.00
Disclosure

SEC source: 0000950170-24-007427 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $13.28 $0.00
Disclosure

SEC source: 0000950170-24-005420 · ownership.xml · derivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 10,000 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 133 $81.06 $10,780.98
Disclosure

SEC source: 0000950170-24-005420 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $81.045 to $81.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 9,867 $80.40 $793,306.80
Disclosure

SEC source: 0000950170-24-005420 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,508

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 16:30 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 10,000 $13.28 $132,800.00
Disclosure

SEC source: 0000950170-24-005420 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 18:46 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 1,461 $0.00 Strike: $38.46 $0.00
Disclosure

SEC source: 0000950170-23-033565 · ownership.xml · derivative · entry 7

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,539

Underlying: Common Stock · 1,461 shares

Expires 2031-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 18:46 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 3,539 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000950170-23-033565 · ownership.xml · derivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,710

Underlying: Common Stock · 3,539 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 18:46 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 5,000 $95.37 $476,850.00
Disclosure

SEC source: 0000950170-23-033565 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $95.00 to $95.60, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 18:46 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 1,461 $38.46 $56,190.06
Disclosure

SEC source: 0000950170-23-033565 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

Read SEC document
July 18, 2023 Filed Jul 19, 2023 18:46 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 3,539 $16.14 $57,119.46
Disclosure

SEC source: 0000950170-23-033565 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 16:31 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 2,974 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000950170-23-033216 · ownership.xml · derivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,249

Underlying: Common Stock · 2,974 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F6 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 16:31 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,225 $90.02 $200,294.50
Disclosure

SEC source: 0000950170-23-033216 · ownership.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 14,776

F4 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 12, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range

Read SEC document
July 13, 2023 Filed Jul 17, 2023 16:31 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,974 $90.05 $267,808.70
Disclosure

SEC source: 0000950170-23-033216 · ownership.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
July 13, 2023 Filed Jul 17, 2023 16:31 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 2,974 $16.14 $48,000.36
Disclosure

SEC source: 0000950170-23-033216 · ownership.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,349

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 2,026 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · derivative · entry 9

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,223

Underlying: Common Stock · 2,026 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · derivative · entry 8

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,249

Underlying: Common Stock · 10,000 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F8 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,775 $90.04 $249,861.00
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · nonDerivative · entry 6

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Khayal Family 2021 Irrevocable Trust

Disclosed balance after: 17,001

F6 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 12, 2022.

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.16, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 2,026 $90.02 $182,380.52
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · nonDerivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,375

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.07, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5 · balance_after: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 1,300 $86.09 $111,917.00
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · nonDerivative · entry 4

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,401

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $86.01 to $86.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 SaleCommon Stock 8,700 $85.44 $743,328.00
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · nonDerivative · entry 3

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,701

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.00 to $85.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 2,026 $16.14 $32,699.64
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · nonDerivative · entry 2

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,401

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

Read SEC document
April 21, 2023 Filed Apr 25, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionCommon Stock 10,000 $16.14 $161,400.00
Disclosure

SEC source: 0000899243-23-011646 · doc4.xml · nonDerivative · entry 1

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 17:00 UTC TransMedics Group, Inc. TMDX · Entity 4261 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0000899243-23-006757 · doc4.xml · derivative · entry 5

Khayal Tamer I · CIK 0001430462 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,249

Underlying: Common Stock · 10,000 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F5 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.